Publicaciones en colaboración con investigadores/as de Hospital de la Santa Creu i Sant Pau (8)

2022

  1. Industrial By-Products As a Novel Circular Source of Biocompatible Extracellular Vesicles

    Advanced Functional Materials, Vol. 32, Núm. 29

2012

  1. The EMT signaling pathways in endometrial carcinoma

    Clinical and Translational Oncology, Vol. 14, Núm. 10, pp. 715-720

2008

  1. Nuclear factor-κB activation is associated with somatic and germ line RET mutations in medullary thyroid carcinoma

    Human Pathology, Vol. 39, Núm. 7, pp. 994-1001

  2. Promoter hypermethylation and reduced expression of RASSF1A are frequent molecular alterations of endometrial carcinoma

    Modern Pathology, Vol. 21, Núm. 6, pp. 691-699

2006

  1. PIK3CA gene mutations in endometrial carcinoma. Correlation with PTEN and K-RAS alterations

    Human Pathology, Vol. 37, Núm. 11, pp. 1465-1472

2005

  1. Immunohistochemical analysis of PTEN in endometrial carcinoma: A tissue microarray study with a comparison of four commercial antibodies in correlation with molecular abnormalities

    Modern Pathology, Vol. 18, Núm. 5, pp. 719-727

  2. Survivin expression in endometrial carcinoma: A tissue microarray study with correlation with PTEN and STAT-3

    International Journal of Gynecological Pathology, Vol. 24, Núm. 3, pp. 247-253

2004

  1. Abnormalities in the NF-κB family and related proteins in endometrial carcinoma

    Journal of Pathology, Vol. 204, Núm. 5, pp. 569-577